Atherosclerosis and restenosis: Is there a role for rage? Peter NawrothAngelika BierhausDavid M. Stern OriginalPaper Pages: 11 - 16
Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis Louis J. IgnarroClaudio Napoli OriginalPaper Pages: 17 - 23
Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes Bart E. MuhsPaul GagnePeter Sheehan OriginalPaper Pages: 24 - 29
FFAs: Do they play a role in vascular disease in the insulin resistance syndrome? Sudha S. ShankarHelmut O. Steinberg OriginalPaper Pages: 30 - 35
ACE inhibitors and mineralocorticoid receptor blockade in patients with congestive heart failure John W. Funder OriginalPaper Pages: 36 - 40
Rimonabant: A novel treatment for obesity and the metabolic syndrome Muhammad HouriRichard E. Pratley Clinical Trials Report Pages: 43 - 44
PPAR ligands: Potential therapies for metabolic syndrome Taro E. AkiyamaPeter T. MeinkeJoel P. Berger OriginalPaper Pages: 45 - 52
Interactions between obstructive sleep apnea and the metabolic syndrome Anna SvatikovaRobert WolkVirend K. Somers OriginalPaper Pages: 53 - 58
Erectile dysfunction: Interrelationship with the metabolic syndrome Glenn MatfinAli JawaVivian A. Fonseca OriginalPaper Pages: 64 - 69
The evolving role of inflammation in obesity and the metabolic syndrome Yong-Ho LeeRichard E. Pratley OriginalPaper Pages: 70 - 75